Find uplifting stories about heroes, innovations, and solutions
19438 results for "weight loss programs"
Cancer survivors struggling with treatment-related weight gain now have a personalized path forward. Sylvester Cancer Center just launched RENEW, a 12-week program designed specifically for safe weight loss after cancer treatment.
Amazon's One Medical is bringing weight-loss drug treatment into primary care offices nationwide, offering patients a safer alternative as demand for medications like Ozempic surges. The move addresses growing concerns about patients receiving improper care from standalone telehealth providers.
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
Millions of Medicare patients will soon access weight loss medications for just $50 a month through a new federal program. The 18-month pilot marks the first time Medicare will help pay for drugs prescribed solely for obesity.
Millions of seniors struggling with obesity can now access weight-loss medications for just $50 monthly, down from over $1,000. A new federal program launching July 1 makes life-changing treatments affordable for the first time.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
Postmenopausal women combining hormone therapy with a popular weight loss drug lost 35% more weight than those taking the medication alone. The finding could transform how millions of women manage weight gain after menopause.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
A tiny molecule discovered using AI mimics Ozempic's weight loss effects without the nausea, constipation, or muscle loss. Animal studies show the peptide targets only the brain's appetite center, not the entire digestive system.
A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
Scientists are testing a breakthrough obesity treatment that helps people lose up to a third of their body weight without sacrificing muscle mass. The triple-action drug retatrutide could solve one of the biggest problems with current weight-loss medications.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
A new diabetes treatment from Eli Lilly helped patients lose 15% of their body weight while improving blood sugar control, potentially becoming the most effective weight loss diabetes drug yet. The results offer hope for millions who struggle to shed pounds while managing their condition.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Ff8%2Ff8%2Ff8f86afc-d21d-40cc-86c9-e212d1e51222%2Fleslie_leinwand_snake_research_0181.jpg)
Scientists discovered an appetite-suppressing molecule in python blood that helped obese mice lose 9% of their body weight without the stomach problems that plague current weight-loss drugs. This breakthrough could lead to a new generation of treatments inspired by nature's most extreme fasters.
Danish scientists discovered that losing weight doesn't just shrink fat cells—it actually helps regenerate healthier fat tissue. The breakthrough research shows that even modest weight loss can reverse obesity-related inflammation and restore fat tissue to a state resembling lean, healthy individuals.
A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.
Two major clinical trials show people can maintain their weight loss by switching to lower doses or once-daily pills after initial treatment. The findings offer hope for tackling one of obesity care's biggest challenges: keeping weight off after losing it.
Showing 20 of 19438